Th e purpose of this study is to determine erythrocyte sedimentation rate
INTRODUCTION
Crimean-Congo haemorrhagic fever (CCHF) disease occur when individual infected by Bunyaviridae family member genus of Nairovirus. Th is virus aff ects human health and has a high geographic distribution among the disease carried by ticks [] . Th e infection of CCHF disease occurrence is possible by biting of tick contact with people who have this infection in their acute phase of CCHF disease and by contacting blood products of infected animals [, ] . Th e clinical symptoms of CCHF are non specifi c. Th e typical symptoms are high fever, headache, fatigue, joint aches, muscle ache, abdomen ache and diarrhoea without blood. In addition, patients may have advanced haemorrhagic symptoms [, ] . CCHF infection in some individuals causes vascular leakage, fever and the disease which characterized with coagulopathy [, ] . To diagnose CCHF, methods based on the isolation of the virus or the virus RNA from blood and tissue samples, and serologic identification of virus antigen and antibodies formed against the virus. Recently, molecular diagnosis methods are also successfully applied [] . Acute phase response (APR) is a series of infl ammatory responses of the host against infection and trauma, and is manifested via pyrogen cytokines that cause fever [] . Th e role of APR is to isolate and neutralize pathogens, prevent the entry of further pathogens by minimizing tissue injury, initiate the repair process and thus assure rapid re-institution of normal physiological functioning of the homeostatic mechanisms of the host . Proteins, whose serum or plasma levels increase or decrease in APR are called acute phase proteins or acute phase reactants. Recent studies have suggested that determining the concentrations of acute phase proteins in plasma or serum provides important diagnostic information regarding the diagnosis and prognosis of the disease [, ] . The most commonly used acute phase pro-teins for this purpose include C -reactive protein (CRP), and erythrocyte sedimentation rate (ESR). Although serum amyloid-A (SAA) is known to be more sensitive compared to both CRP and ESR, its use is not yet widespread [] . SAA is one of the most important positive acute phase proteins, and an amphipathic apolipoprotein weighing  kDa. SAA production is mainly induced in the liver by some cytokins (IL-β, IL- and TNF-α) during APR. As a result, under normal physiological conditions, SAA may increase up to  times the - μg/ml level [, ] . SAA is induced in cases of infl ammation, and bacterial and fungal infection, and reaches high levels (up to  mg/L) in the serum. These protein is accepted as a supportive marker for the diagnosis and prognosis of inflammatory and autoimmune diseases [] . A milder increase (up to  mg/L) is observed in SAA expression in various acute and viral infections [, ] . Th erefore, SAA is a useful infl ammatory marker in viral infections where clinical diff erential diagnosis is diffi cult and viral isolation is not possible [] . If the SAA is secreted into circulation, it binds to the plasma high density lipoprotein (HDL) with removed apolipoprotein A-I in a short time [] . In the absence of HDL, SAA is linked to low density lipoprotein (LDL) or very low-density lipoprotein (VLDL) [] . It has been expressed that these relations and interactions between HDL and SAA may change the HDL metabolism and cholesterol transport during acute inflammation [, ] . Furthermore, SAA can remove excess cholesterol from sites of infl ammation [] , and has been suggested to play a role in cholesterol effl ux within the adipose tissue [] . A study by Olsson et al established a transgenic mouse model with adipose tissuespecifi c expression of human serum amyloid A (hSAA). Olsson et al. [] demonstrated that increased adipose tissue derived hSAA plasma levels from high fat fed hSAA mice, correlated with amount of adipose tissue and, in plasma, hSAA concentration peaked in HDL containing fractions. Serum levels of the acute phase reactants CRP and ESR have important roles in diff erentiating between bacterial and viral diseases [] . However, CRP often does not attain detectable levels in viral diseases [] . Th erefore, serum levels of ESR and CRP are expected to remain normal in CCHF, which is a viral disease. Recent studies have reported SAA to be a more sensitive acute phase reactant in determining viral infections compared to CRP [, ] . In this study, our objective was to determine whether SAA was a more benefi cial marker in establishing a pre-diagnosis of CCHF compared to ESR and CRP. A recent study has demonstrated that reduced cholesterol levels in plasma membrane prevented infection with Crimean-Congo Hemorrhagic Fever virus (CCHFV) signifi cantly [] . Th erefore, we also aimed to determine cholesterol levels in patients with CCHF, since CCHF virus infection and SAA levels have been suggested to be associated with cholesterol levels. Finally, we aimed to investigate the relationship between these parameters and disease severity.
MATERIAL AND METHODS

Study population
This prospective study was conducted between  and  in Cumhuriyet University Hospital in Sivas, a city located in central Anatolia. The study protocol was approved by the Human Ethics Committee of the Cumhuriyet University Faculty of Medicine. Informed consent was obtained from each patient. This work is supported by the Scientific Research Project Fund of Cumhuriyet University under the project number T-. Suspected cases with CCHF were defined as those who had clinically observed sign and symptoms (e.g. fever, nausea, vomiting, myalgia, bleeding), epidemiological risk factors (being bitten by tick or being a farmer) and laboratory data consisting of a platelet (PLT) count of < /mm, white blood cell (WBC) count of </mm, and elevated liver enzymes. All patients were followed up at the Department of Infectious Diseases and Clinical Microbiology at Cumhuriyet University Hospital. The presence of serum IgM of patients was tested by ELISA and/or of the genomic segments of the CCHF virus by reverse-transcription polymerase chain reaction (RT-PCR). In acute and convalescent phase sera. Acute phase blood sera were collected within  hours of hospitalization. A convalescent phase serum sample was obtained from each patient after at least  days. Following collection of serum samples were immediately sent to the Virology Laboratory of Refik Saydam National Public Health Agency (RSNPHA) Ankara, Turkey, for serologic and virologic analyses to confi rm the diagnosis of CCHF. Th e presence of CCHFV RNA was tested in blood sera using a TaqMan-based real time RT-PCR assay as described by Yapar et al. [] . Th e defi nitive diagnosis of CCHF infection was based on typical clinical and epidemiological fi ndings and the detection of CCHF virus-specifi c IgM by enzyme-linked immunosorbent assay (ELISA) or of genomic segments of the CCHF virus by reverse-transcription polymerase chain reaction (RT-PCR). Written informed consent was obtained from patients or their family members. All CCHF patients were classified into two groups in terms of disease severity (severe, non-severe), according to the predictive factors for fatal outcome criteria reported by Swanepoel et al. [] . Thirty-nine healthy adult volunteers who had no infections or immune system diseases such as rheumatoid arthritis, psoriasis and sarcoidosis, were included in this study as a control group. The control group consisted of volunteers from the Cumhuriyet University staff .
Blood collection
Venous blood samples were collected in tubes after an -h fast and immediately stored at ° C. Next, the serum was separated from the cells and fi brines by centrifugation at  x g for  min and stored in several aliquots at -° C until assayed.
Measurement of SAA levels in sera
Human SAA levels were measured with ELISA kit (Human SAA Cytoscreen ELISA Immunoassay kit Catalog KHA, BioSource International, Camarillo, CA, USA) according to instructions of the manufacturers [] .
Measurement of CRP levels
Serum CRP levels were measured with nephelometric method using 'Beckman Coulter™ Immage Analyzer System at Microbiology Laboratory of Cumhuriyet University Medical School Education and Research Hospital [] .
Determination of ESR
ESR in patient and control groups were determined with Mix-Rate x vital diagnostic device at Hematology Laboratory of Cumhuriyet University Medical School Education and Research Hospital.
Statistical analysis
Parametric data are expressed as the mean ± standard deviation and categorical data as percentages. The Statistical Package for the Social Sciences (SPSS) version  for Windows (SPSS Inc., Chicago, IL, USA) was used for the statistical analysis. Parametric data were evaluated by the independent sample t-test and categorical data by the chisquared test. A p value ≤. was considered as signifi cant.
RESULTS
Forty CCHF patients and  control subjects were recruited for the study. Of the CCHF patients,  (. ) were female and  (. ) male, and the mean age was .±. years. In the control group,  (. ) individuals were male and  (. ) were female, with a mean age of . ± . years. Th ere were no signifi cant diff erences in the age or sex ratio between CCHF patients and controls (Table ; p>.). ESR, CRP and SAA levels in CCHF patients were significantly higher than were those determined for the control group (p<.). HDL, LDL and total Cholesterol levels in patients with CCHF were meaningfully less than the control group (p<.; Table ) . We found no significant difference in serum CRP, SAA, HDL, LDL, total Cholesterol levels and ESR between severe and non-severe patients (p>.; Table  ). In addition, an inverse correlation coefficient (r=-.) was determined between HDL and CRP levels in the patient group. However, this correlation coefficient was statistically insignificant (p=.; p>.). A statistically significant correlation coefficient (r=-.) was determined between CRP and ESR in the patient group (p=.; p<.).
DISCUSSION
CCHF is a viral hemorrhagic fever disease, highly threatening for the health. Th e mortality rate of the disease may be about . Various mortality rates of - were also reported [, ] tick are considered in establishing this pre-diagnosis. However, CCHF might be mistaken for typhus, tularemia and lyme which are other tick-borne diseases with similar clinical pictures [, ] . Establishment of an exact diagnosis is necessary, but possible in only a couple of reference laboratories in most countries. Th erefore, this process takes a certain period of time which might be as long as - days. Early diagnosis and initiation of antibiotic treatment in cases of bacterial infections is crucial particularly in patients with poor general condition. Acute phase reactants including CRP and ESR are used in diff erentiating between bacterial and viral infections since years. Although SAA has been suggested to be more sensitive, it is not used commonly in clinical practice. CRP is the preferred routine follow-up parameter in most centers since it is both practical and less expensive. Although CRP is the most well-known and commonly used marker of infection, CRP-alone sometimes proves inadequate in early diagnosis of infection. Symptoms often arise prior to elevation of CRP levels. Several studies have thus investigated the role of SAA, another acute phase protein, in the diagnosis and follow-up of various diseases. SAA levels have been determined to be signifi cantly elevated in several diseases including common fl u and infl uenza [] , rubella and measles (p<.) [] . However, there are no studies in the literature examining the levels of SAA, CRP, ESR and cholesterol levels in patients with CCHF. In this study, our objectives were to determine ESR, SAA, CRP and cholesterol levels in patients with CCHF and to determine the relationship of these parameters with establishment of pre-diagnosis, prognosis and pathogenesis of the disease. SAA and CRP levels were found signifi cantly higher in the patient group compared to the controls (p<.), whereas no signifi cant diff erences were determined between the groups in terms of ESR (p>.; Table ) . CRP is a more sensitive and reliable marker of acute inflammatory events compared to ESR [] . However, CRP often remains below the detectable threshold in viral infections whereas SAA is detectable. Even slight increases are detectable in SAA since this marker has higher physiological levels than CRP and remains elevated for longer than CRP [, ] . Several studies have demonstrated that SAA provides a sooner and more rapid increase, and that it is elevated in the acute phase of  of all viral infections [, ] . Additionally, SAA expression is more prominently increased in bacterial and fungal infections (up to  mg/L) compared to viral infections (up to  mg/L) [] . This suggests that SAA is a beneficial marker in differentiating viral infections from bacterial ones. In our study, SAA and CRP levels were found significantly higher in the patient group compared to the controls (p<.), whereas no significant differences were determined between the groups in terms of ESR (p>.; Table    ). Th erefore, we suggest that ESR is not a good marker to determine CCHF which is an acute viral disease and that the use of CRP-alone might be inadequate. Th at is why, together use of CRP and SAA in establishing a diagnosis of CCHF might increase the rates of sensitivity and accuracy. Our study also compares the HDL, LDL and total cholesterol levels of patient and control groups, fi nding a meaningful difference (p<.) for all these parameters between the two groups. In addition, no signifi cant correlations were determined between CRP and HDL (r=-.), or ESR and SAA (r=-.), despite the presence of signifi cant correlation between SAA and HDL levels (r=-.) in our study. As also seen in Table  despite a very serious drop in the HDL level in CCHF patients, there is also a remarkable fall in LDL and total cholesterol levels. Th at is why, lipoprotein and cholesterol metabolism generally change in these patients. And this may be associated with an increase in the level of SAA secreted into circulation as a result of induction of SAA expression in the liver through the secretion of cytokines depending on viral infection in CCHF patients. Th at is, most probably, the SAA level that increases in circulation as a result of APR which develops in these patients removes more apoA from HDL and binds with this lipoprotein. HDL's structure changes as a result of this binding. Th erefore, this may be a cause of low HDL level in patients with CCHF. Results obtained from a study where the plasma lipoprotein dynamics are studied in patients with severe sepsis support of our fi ndings. In that study, researchers found that cholesterol and HDL level rapidly and meaningfully fell between days  to  in patients with severe sepsis. Moreover, a positive correlation (r=., p<.) was found between SAA concentration in plasma CRP and HDL. As a result of these fi ndings, it is expressed that SAA was the main apoprotein in HDL during the onset of sepsis. Besides, the reason underlying the drop in total cholesterol is mainly linked to the fall in HDL level [] . SAA is linked to LDL or VLDL in the absence of HDL in blood circulation [] . And because the HDL level is very low in CCHF patients, some of SAA is linked to LDL and other lipoproteins. Th is may be considered as one of the causes of low LDL level in CCHF patients. It is considered that the decrease in the LDL level, especially the HDL, is one of the factors causing fall in total cholesterol level in CCHF patients. We believe that SAA interacts with lipoproteins as a result of infl ammation, indirectly contributing to all such falls in the cholesterol levels in CCHF patients.
In the in-vitro study of Simon et al. [] performed with cell cultures, nucleocapsid protein and viral RNA levels of CCHFV have been found significantly decreased in cells with diminished cholesterol via methyl-β-cyclodextrin administration. In other words, reduced cholesterol levels in cellular plasma membrane have prevented CCHFV infec-tion signifi cantly. On the other hand, this process has been observed to be reversed when exogen cholesterol was added. According to the results of their study, authors have suggested that cholesterol is involved in the early stages of CCHFV replication cycle [] . Similarly, our results also supported the notion that cholesterol has an important role in the pathogenesis of CCHF. However, further studies should be performed to further clarify this hypothesis. Analysis of all the study parameters in terms of CCHF severity demonstrated no statistically signifi cant diff erences between severe and non-severe cases of CCHF (p>.). Results of our study indicate that ESR, CRP, SAA, HDL and total cholesterol levels are not good markers of prognosis in CCHF disease.
CONCLUSION
CRP is used as a sensitive inflammatory marker in bacterial infections but its value is limited in acute viral infections due to minimal elevation compared to bacterial infections. SAA increases sooner and more markedly than CRP; and contrary to CRP, SAA is elevated markedly in bacterial as well as viral infections. Parallel use of CRP and SAA might increase the rates of sensitivity and accuracy of these acute phase proteins in establishing a diagnosis of CCHF infection. However, ESR, CRP, SAA, HDL and total cholesterol are not deemed as good markers of prognosis in CCHF disease. Additionally, cholesterol levels were significantly decreased in patients with CCHF, which was suggested to be associated with increased circulatory levels of SAA.
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